Local Biotech Company is Improving Clinical Care for Animals
PetVet Dx celebrated recent expansion and future plans at a community event Friday
NEW ORLEANS (March 31, 2023) Local biotech company PetVet Dx hosted a community event last Friday to celebrate their recent expansion in the New Orleans BioInnovation Center (NOBIC.) The program capped off with a donation to both the New Orleans Police Department Canine Unit and Audubon Zoo.
PetVet Dx is a therapeutic management company specializing in Infectious Disease and Cancer molecular diagnostic testing to improve clinical care in all species of animals. Its revolutionary technology provides an effective and efficient testing product for veterinarians, farmers, and pet owners.
“As a company, we felt it was important to thank the community we are a part of,” said David Kutrucz, President of PetVetDX. “Support the NOPD Canine Unit and Audubon Zoo just made sense. Not only are we proud to make a monetary donation, we also donated our diagnostic services.”
PetVet Dx offers the most comprehensive infectious disease tests and identification of antibiotic resistance genes on the market. PetVet Dx is the only laboratory in the nation utilizing and offering the most advanced, CDC-recommended technology to produce the most comprehensive reporting within 24 hours with an unequaled accuracy rate of 99.8%.
In addition, PetVet Dx’s testing solution provides you with pharmacological antibiotic medication reporting to help veterinarians, pet owners, and farmers better understand identified infections and their treatment.
For more information, please visit here.
PetVet Dx: PetVet Dx is a therapeutic management company specializing in targeted PCR molecular diagnostics to improve clinical care in all species of animals. Our revolutionary molecular technology provides a firm foundation for diagnostics in animal health services for veterinarians, farmers, and pet owners. PetVet Dx believes that the only diagnostic test that should be performed is one that will improve an animal’s overall outcome.